Novartis posts better-than-expected first-quarter sales, raises full-year guidance
Swiss pharmaceutical firm Novartis on Tuesday reported better-than-expected first-quarter sales and raised its full-year guidance.
You are not logged in so some information on this page has been withheld. To see more, please log in.
Novartis
since
auto-detected in 83 stories
36 days ago
Novartis posts better-than-expected first-quarter sales, raises full-year guidance
Swiss pharmaceutical firm Novartis on Tuesday reported better-than-expected first-quarter sales and raised its full-year guidance.
55 days ago
Novartis plans to invest $23 billion in U.S. plants as Trump renews drug tariff threats
Swiss drugmaker Novartis said it plans to spend $23 billion to build and expand 10 facilities in the U.S. as it grapples with Trump's threats of drug tariffs.
77 days ago
Swiss drugmakers Novartis and Roche ditch some diversity programs on U.S. concerns
Swiss drugmaker Roche has abandoned global diverse workforce targets, and compatriot Novartis is ending its use of diverse panels for U.S. hiring.
85 days ago
European markets open lower; Novo Nordisk, Novartis retreat
European markets opened lower as global markets buckle amid anxiety that the U.S. economy will suffer because of Trump's trade policies.
page 1 of 1